Myalepta (metreleptin) 5.8 mg vial: shortage and mitigation plan
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Myalepta
|
| Active substance |
Metreleptin
|
| Therapeutic area (MeSH) |
Lipodystrophy, Familial Partial
|
| Procedure number |
EMEA/H/C/004218
|
| DHPC type |
Medicine shortage
|
| Human ATC code |
A16AA
|
| Dissemination date |
03/03/2023
|